Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
CVS Health Corp
(NY:
CVS
)
55.54
-1.53 (-2.68%)
Official Closing Price
Updated: 7:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about CVS Health Corp
< Previous
1
2
3
4
5
6
7
8
9
...
43
44
Next >
From Apple to Wayfair: A Lot of Earnings Results to Cover
May 07, 2024
Whether it's smartphones or soy lattes, consumers are pickier right now. The companies that are keeping things convenient and creating value offerings are winning; the ones that aren't are struggling.
Via
The Motley Fool
CVS Health Options Trading: A Deep Dive into Market Sentiment
May 07, 2024
Via
Benzinga
3 Healthcare Stocks to Sell in May Before They Crash & Burn
May 07, 2024
With the stock market uncertain and rising theft, these are three healthcare stocks to sell in the event of a market downturn.
Via
InvestorPlace
NVIDIA To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Tuesday
May 07, 2024
Via
Benzinga
CVS Health Unusual Options Activity
May 03, 2024
Via
Benzinga
Expert Outlook: CVS Health Through The Eyes Of 11 Analysts
May 02, 2024
Via
Benzinga
CVS Is Sick
May 01, 2024
One would figure the nation’s biggest pharmacy would be a safe, conservative investment. Nope. CVS has lost about HALF its value in just two years.
Via
Talk Markets
Why CVS Health Stock Plunged Today
May 01, 2024
Its profits took a hit as its insurance benefit payouts rose.
Via
The Motley Fool
The 7 Most Undervalued Stocks to Buy Now: Q2 Edition
May 06, 2024
These undervalued stocks have the potential to deliver substantial returns as they rebound toward their intrinsic values.
Via
InvestorPlace
3 Insurance Stocks That Could Make You a Millionaire
May 06, 2024
The insurance business can be a great way to build wealth over time.
Via
The Motley Fool
Last Week's Worst-Performing Stocks: Are These 15 Large-Cap Stocks In Your Portfolio? (April 28-May 4, 2024)
May 05, 2024
15 large-cap stocks had a rough week, with CVS, Starbucks, and DoorDash all taking major hits. Analysts have lowered price targets on many.
Via
Benzinga
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
May 04, 2024
These highly advantaged businesses have what they need to keep raising their dividend payouts.
Via
The Motley Fool
Unpacking the Latest Options Trading Trends in CVS Health
April 30, 2024
Via
Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Is This Beaten-Down Dividend Stock a Buy?
April 27, 2024
The company has one major strength: It offers essential services.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
May 02, 2024
Via
Benzinga
CVS Health (CVS) Q1 2024 Earnings Call Transcript
May 01, 2024
CVS earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 01, 2024
Via
Benzinga
Moody’s, Booking, DraftKings, Amgen Stocks In Focus Ahead Of Earnings
May 01, 2024
American stocks were mixed on Wednesday as the earnings season continued and as investors waited for the latest Federal Reserve decision. The Dow Jones rose by over 65 points while the S&P 500 and...
Via
Talk Markets
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 01, 2024
Via
Benzinga
CVS Shares Dump On Earnings Miss, Outlook Slashed On Rising Medical Costs
May 01, 2024
CVS shares plunged after first-quarter revenue and adjusted earnings missed Wall Street's average expectations. The drugstore chain also slashed its full-year profit outlook, citing rising medical...
Via
Talk Markets
Topics
Earnings
Exposures
Financial
CVS Stock Earnings: CVS Health Misses EPS, Misses Revenue for Q1 2024
May 01, 2024
CVS stock results show that CVS Health missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Rising Cost For Health Insurers Bites CVS Health's Q1 Profit, Stock Tanks
May 01, 2024
CVS Health Q1 sales of $88.4 billion, up 3.7% Y/Y. Adjusted EPS at $1.31, down from $2.20. Health Care Benefits segment sees strong growth, while Health Services segment faces challenges. Revised 2024...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 01, 2024
Via
Benzinga
CVS Health Dives To 3-Year Low On Medicare Cost Surge
May 01, 2024
CVS earnings tumbled more than expected on a surge in Medicare costs.
Via
Investor's Business Daily
Walmart Pulls Plug On Health Centers, Telehealth; Respite For TDOC?
April 30, 2024
Walmart is shutting down its health centers and virtual care offering, continuing a broader shakeup in telehealth. WMT stock is near a buy point.
Via
Investor's Business Daily
AbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales
April 29, 2024
The company is projected to bring in increasing sales through at least 2029.
Via
Investor's Business Daily
Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally
May 01, 2024
A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASDAQ:AMD)
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
3 Value Stocks to Buy on the Dip: April 2024
April 29, 2024
With the tech sector fallout leading to some red ink, here are the value stocks to buy on the dip for astute investors.
Via
InvestorPlace
Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost
April 26, 2024
Evernorth Health Services' initiative to offer Humira biosimilar with $0 out-of-pocket costs for patients. Save an average of $3,500 yearly.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
43
44
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.